Point of Care Infectious Disease Testing Market Size, Share & Trends Report

Point of Care Infectious Disease Testing Market Size, Share & Trends Analysis Report By Disease (HIV POC, HBV POC, Influenza/Flu POC, TB & drug-resistant TB POC), By End-use, And Segment Forecasts, 2018 - 2025

Report ID: GVR-1-68038-569-4
Number of Pages: 145
Format: Electronic (PDF)

Historical Range: 2014 - 2016
Industry: Healthcare

Market Segmentation

Point of Care Infectious Disease Testing Disease Outlook (Revenue, USD Million, 2014 - 2025)
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
- HSV (Herpes Simplex Virus) POC
- Other infectious disease POC
Point of Care Infectious Disease Testing End-Use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
Point of Care Infectious Disease Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America
- North America Disease Outlook (Revenue, USD Million, 2014 - 2025)
  - HIV POC
  - Clostridium difficile POC
  - HBV POC
  - Pneumonia or Streptococcus associated infections
  - Respiratory syncytial virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and drug-resistant TB POC
  - HSV (Herpes Simplex Virus) POC
  - Other infectious disease POC
- North America End-use Outlook (Revenue, USD Million, 2014 - 2025)
  - Hospitals
  - Clinics
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratories
  - Others
- The U.S.
  - The U.S. Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - The U.S. End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
- Canada
  - Canada Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - Canada End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
Europe
- Europe Disease Outlook (Revenue, USD Million, 2014 - 2025)
  - HIV POC
  - Clostridium difficile POC
  - HBV POC
  - Pneumonia or Streptococcus associated infections
  - Respiratory syncytial virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and drug-resistant TB POC
  - HSV (Herpes Simplex Virus) POC
  - Other infectious disease POC
- Europe End-use Outlook (Revenue, USD Million, 2014 - 2025)
  - Hospitals
  - Clinics
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratories
  - Others
- Germany
  - Germany Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - Germany End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
- The U.K.
  - The U.K. Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - The U.K. End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
Asia Pacific
- Asia Pacific Disease Outlook (Revenue, USD Million, 2014 - 2025)
  - HIV POC
  - Clostridium difficile POC
  - HBV POC
  - Pneumonia or Streptococcus associated infections
  - Respiratory syncytial virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and drug-resistant TB POC
  - HSV (Herpes Simplex Virus) POC
  - Other infectious disease POC
- Asia Pacific End-use Outlook (Revenue, USD Million, 2014 - 2025)
  - Hospitals
  - Clinics
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratories
  - Others
- Japan
  - Japan Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - Japan End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
- China
  - China Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - China End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
Latin America
- Latin America Disease Outlook (Revenue, USD Million, 2014 - 2025)
  - HIV POC
  - Clostridium difficile POC
  - HBV POC
  - Pneumonia or Streptococcus associated infections
  - Respiratory syncytial virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and drug-resistant TB POC
  - HSV (Herpes Simplex Virus) POC
  - Other infectious disease POC
- Latin America End-use Outlook (Revenue, USD Million, 2014 - 2025)
  - Hospitals
  - Clinics
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratories
  - Others
- Brazil
  - Brazil Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - Brazil End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others
MEA
- MEA Disease Outlook (Revenue, USD Million, 2014 - 2025)
  - HIV POC
  - Clostridium difficile POC
  - HBV POC
  - Pneumonia or Streptococcus associated infections
  - Respiratory syncytial virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and drug-resistant TB POC
  - HSV (Herpes Simplex Virus) POC
  - Other infectious disease POC
- MEA End-use Outlook (Revenue, USD Million, 2014 - 2025)
  - Hospitals
  - Clinics
  - Home
  - Assisted Living Healthcare Facilities
  - Laboratories
  - Others
- South Africa
  - South Africa Disease Outlook (Revenue, USD Million, 2014 - 2025)
    - HIV POC
    - Clostridium difficile POC
    - HBV POC
    - Pneumonia or Streptococcus associated infections
    - Respiratory syncytial virus (RSV) POC
    - HPV POC
    - Influenza/Flu POC
    - HCV POC
    - MRSA POC
    - TB and drug-resistant TB POC
    - HSV (Herpes Simplex Virus) POC
    - Other infectious disease POC
  - South Africa End-use Outlook (Revenue, USD Million, 2014 - 2025)
    - Hospitals
    - Clinics
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratories
    - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.